The Type 1 Diabetes Prevention Trial, also known as the Intranasal Insulin Trial (INIT II), is part of a coordinated global effort to develop a vaccine for type 1 diabetes. The trial, which began in 2006, is jointly funded by the National Health and Medical Research Council (NHMRC) and the Juvenile Diabetes Research Foundation (JDRF), through the Diabetes Vaccine Development Centre (DVDC).

If successful, this vaccine could prevent type 1 diabetes and the need for daily insulin injections in people at risk.

Over the past 5 years we have screened over 6,500 people in Australia >> Find out more

  • UPDATE: NSW and VIC are fighting it out for the top spot in the Type 1 Diabetes Prevention Trial's race to ...
    >> Read more
  • Ted and Matthew Frost are among the almost 600 Australians who have recently registered and had a blood test for ...
    >> Read more
  • We are well on our way to 600 registrations since Boris and Adam traveled AUS and landed in your letterbox! We ...
    >> Read more
  • Did you know we have a YouTube channel? You can view our current and previous videos all in the one place!
    StopDiabetesAUSNZwww.youtube.comThe ...
    >> Read more
  • LATEST NEWS - We have just received our 500th registration for the Type 1 Diabetes Prevention Trial! Thank you ...
    >> Read more

  • Are you Eligible?

    Anyone who is aged between 4 and 30 and has type 1 diabetes in his or her family can potentially participate in the Type 1 Diabetes Prevention Trial. Get involved today and write yourself in
    >> Find out more

  • Spread the Word

    Click the icons below to email a friend or spread the word via Facebook or Twitter. The green ShareThis icon also lets you tell your friends via LinkedIn, Google and Yahoo! So, no excuses!

  • Learn About Diabetes

     Type 1 diabetes, previously known as juvenile or early-onset diabetes, is an autoimmune disease in which the body's immune system destroys the cells that produce insulin. Located in the pancreas, these cells are called beta cells. Although less co
    >> Find out more